If You Invested in Covetrus Inc (CVET)
See the CVET overviewWhat $1,000 or $10,000 in CVET Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Feb 8, 2019 |
|---|---|---|---|---|
| $1,000 | $1,133 +13% | — | — | $512 -49% |
| $10,000 | $11,328 +13% | — | — | $5,118 -49% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2022-10-12. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for CVET$1,000 Investment Over Time
CVET vs S&P 500Year-by-Year Returns
CVET annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2019Feb 8 to Dec 31 | $41.01 | $13.20 | -67.8% | -67.8% |
| 2020 | $13.20 | $28.74 | +117.7% | -29.9% |
| 2021 | $28.74 | $19.97 | -30.5% | -51.3% |
| 2022Dec 31, 2021 to Oct 12 | $19.97 | $20.99 | +5.1% | -48.8% |
About Covetrus Inc
Healthcare · NASDAQ
Covetrus Inc. is a global animal-health technology and services company that provides products, services, and technology for veterinary practices. The company describes its operating model as a single platform that connects veterinary practice partners with solutions and insights used in animal care and practice operations. Covetrus is headquartered in Portland, Maine, and its historical public-company ticker was CVET on Nasdaq.
The company’s business is centered on the veterinary community. Its offerings include animal-health products, practice services, prescription management capabilities, proprietary brands, and technology tools that support veterinarians, their practices, and patients. Covetrus has described its mission in terms of improving health and financial outcomes for veterinary practice partners by combining distribution, services, and technology into an integrated platform.
As a public company, Covetrus reported activity across geographic operating areas that included North America, Europe, and APAC & Emerging Markets. Company updates referenced demand for prescription management, adoption of its technology stack, growth of proprietary brands, and management of corporate costs as recurring operating themes. Its customer base and operating focus were global, with veterinary practices as the core end market.
The CVET ticker also represents a completed corporate-status history. Former holders of Covetrus common stock had their shares exchanged for cash on October 13, 2022, and later stockholder litigation materials referenced those former holders and the exchange of Covetrus securities. Subsequent company announcements continued to describe Covetrus as an animal-health technology and services company, while the CVET symbol remains a historical reference to the company’s former Nasdaq-listed public equity.
Similar Stocks
See how related companies performed
Frequently Asked Questions
Covetrus Inc investment returns
How much was $1,000 invested in Covetrus Inc worth at its last close?
If you invested $1,000 in Covetrus Inc (CVET) 1 year before its last close, on 2021-10-12, your investment was worth $1,133 on 2022-10-12, a +13.3% price return without dividends, growing at a compounded rate of 13.3% per year (CAGR).
Has Covetrus Inc outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare CVET performance over available time periods.
What is Covetrus Inc's average annual return?
The compound annual growth rate (CAGR) of CVET’s share price over the 1 year to Oct 12, 2022 is 13.3%, without dividends. Individual years vary a great deal, and CVET’s best recent full year was 2020 (+117.7%) while the worst was 2021 (-30.5%).
For informational and educational purposes only, not investment advice.